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Ultrafine particles and ozone 
perturb norepinephrine clearance 
rather than centrally generated 
sympathetic activity in humans
Karsten Heusser  1, Jens Tank  1, Olaf Holz2,3, Marcus May  4, Julia Brinkmann5,6, 
Stefan Engeli5, André Diedrich  7, Theodor Framke8, Armin Koch8, Anika Großhennig8, 
A. H. Jan Danser9, Fred C. G. J. Sweep  10, Christoph Schindler4, Katharina Schwarz2, 
Norbert Krug2,3, Jens Jordan1 & Jens M. Hohlfeld2,3,11
Cardiovascular risk rapidly increased following exposure to air pollution. Changes in human autonomic 
regulation have been implicated based on epidemiological associations between exposure estimates 
and indirect autonomic nervous system measurements. We conducted a mechanistic study to test the 
hypothesis that, in healthy older individuals, well-defined experimental exposure to ultrafine carbon 
particles (UFP) increases sympathetic nervous system activity and more so with added ozone (O3). 
Eighteen participants (age >50 years, 6 women) were exposed to filtered air (Air), UFP, and UFP + O3 
combination for 3 hours during intermittent bicycle ergometer training in a randomized, crossover, 
double-blind fashion. Two hours following exposure, respiration, electrocardiogram, blood pressure, 
and muscle sympathetic nerve activity (MSNA) were recorded at supine rest, during deep breathing, 
and during a Valsalva manoeuvre. Catechols and inflammatory marker levels were measured in venous 
blood samples. Induced sputum was obtained 3.5 h after exposure. Combined exposure to UFP + O3 
but not UFP alone, caused a significant increase in sputum neutrophils and circulating leucocytes. 
Norepinephrine was modestly increased while the ratio between plasma dihydroxyphenylglycol (DHPG) 
and norepinephrine levels, a marker for norepinephrine clearance, was reduced with UFP + O3. Resting 
MSNA was not different (47 ± 12 with Air, 47 ± 14 with UFP, and 45 ± 14 bursts/min with UFP + O3). 
Indices of parasympathetic heart rate control were unaffected by experimental air pollution. Our study 
suggests that combined exposure to modest UFP and O3 levels increases peripheral norepinephrine 
availability through decreased clearance rather than changes in central autonomic activity. Pulmonary 
inflammatory response may have perturbed pulmonary endothelial norepinephrine clearance.
The World Health Organization estimated that air pollution is the 13th leading cause of mortality worldwide1. A 
large proportion of the excess mortality can be attributed to cardiovascular causes2. The risk for acute myocardial 
infarction was increased two and 24 hours following increased fine particle exposure3. Ventricular arrhythmias 
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were also more likely when patients were subject to short-term exposure to fine particles4. During an air pollution 
episode, average resting heart rate and blood pressure were modestly increased. The odds ratio of having hyper-
tensive blood pressure readings was 1.635,6. The rapid increase in blood pressure, heart rate, and cardiovascular 
risk suggests autonomic nervous system involvement with augmented adrenergic drive and parasympathetic 
withdrawal. Indeed, for each 1 mg/m3 increment in workplace exposure to fine particles with ≤2.5 µm mean 
aerodynamic diameter (PM2.5), heart rate variability in 24-hour electrocardiograms decreased 2.66%7. Heart 
rate variability decreased within two hours8 and remained suppressed the following day9. Experimental exposure 
to mixed coarse and fine particles elicited similar responses10. Fine particle exposure was also pressor in rats11,12. 
On the other hand, an air-filtering device was reported to attenuate plasma norepinephrine concentrations in 
humans13. Older persons may be more susceptible to air pollution because of detrimental effects on autonomic 
cardiovascular control as opposed to young subjects14. Indeed, particulate matter and O3 have been shown to 
decrease heart rate variability in this population15. Greater susceptibility may also arise from the ability of nano-
particles to cause localized accumulations after translocation from airways and lungs into the brain via neuronal 
and circulatory pathways16. Furthermore, the adverse effects of air pollution may have greater impact on the 
health status in the elderly17. Ultrafine particles with ≤0.1 µm aerodynamic diameter appear to be particularly 
harmful because they escape broncho-mucociliary clearance and reach alveoli18. Epidemiological studies showed 
associations between ultrafine carbon particle exposure and cardiopulmonary morbidity and mortality which 
may operate as a universal carrier for various chemicals19. Ozone (O3) is another pollutant contributing to adverse 
cardiovascular effects20–22. Airway inflammation is augmented with concomitant exposure to carbon particles 
and O323.
So far, much of the evidence linking air pollutant exposure with changes in human cardiovascular autonomic 
regulation relied on epidemiological studies, exposure estimates, and indirect autonomic nervous system meas-
urements. Moreover, mechanism-oriented studies are rarely conducted in older persons who are more suscep-
tible to air pollution. Therefore, we conducted a study in healthy individuals >50 years, to test the hypotheses 
that short-term experimental exposure to UFP changes the balance between sympathetic and parasympathetic 
cardiovascular control towards sympathetic predominance. We reasoned that combined exposure to particles 
and O3 would have an even greater effect. Our findings suggest that short-term experimental air pollution aug-
ments peripheral norepinephrine availability through changes in peripheral norepinephrine clearance rather than 
increased efferent sympathetic nerve traffic.
Methods
Subjects. We screened 57 healthy subjects >50 years of age. Eight postmenopausal women and 17 men met 
all inclusion and exclusion criteria and entered the study between September 2013 and June 2015. Smokers and 
individuals with clinically apparent cardiovascular and/or pulmonary diseases were excluded. Specifically, we 
excluded patients with asthma of any severity while atopy or atopic rhinitis was not an exclusion criterion. We 
included 1 subject with asymptomatic atopy and 2 subjects with mild or sporadic rhinitis symptoms during their 
respective pollen season. Both had their visits outside of their respective season. We also excluded individuals 
on medications strongly affecting autonomic nervous system function, e. g. norepinephrine reuptake inhibitors, 
whereas stable medication with slight to moderate autonomic effects was tolerated. We did not select subjects 
with regard to their domestic or workplace air pollution.
Twenty participants (6 women and 14 men) completed all three study visits with successful microneurogra-
phy recordings. Two participants had lost substantial amounts of body weight during the study even though we 
had advised all participants not to change their exercise and dietary habits. Because both had begun an intense 
lifestyle intervention including regular physical training, they were excluded before the study was unblinded leav-
ing 18 participants in the primary analysis set. The CONSORT diagram for the trial is shown in Supplementary 
Fig. S1. Characteristics of the study population are given in Table 1.
Study Design and Protocol. The ethics committee of Hannover Medical School approved our study and 
all participants gave written informed consent before enrolment. The methods were carried out in accordance 
with the relevant guidelines and regulations. The study was registered at clinicaltrials.gov (registration num-
ber: NCT01914783, posted: 2013-08-02). In this randomized, sham-controlled, double-blind, three-period, 
three-sequence crossover study participants were exposed to Air (placebo), UFP, and the combination UFP + O3. 
Washout periods between exposures were at least eight weeks. Data were collected at the Fraunhofer Institute 
for Toxicology and Experimental Medicine (Hannover ITEM) and at the Clinical Research Centre of Hannover 
Medical School.
Parameter
Number 18
Male/female 12 / 6
Age [years] 59.2 ± 7.0
Body mass [kg] 85.6 ± 18.7
Height [cm] 176 ± 9
BMI [kg/m²] 27.3 ± 4.7
Table 1. Subject characteristics (mean ± SD). BMI: Body mass index.
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Exposure. We exposed subjects to Air, UFP, or UFP + O3, in a dedicated exposure chamber equipped with 
a bicycle ergometer. UFP (50 μg/m³) and O3 (250 ppb) generation are described in Supplementary Methods24,25. 
Detailed justification for UFP and O3 dosage is given in Supplementary Methods. In brief, the O3 concentration 
used in our study exceeds the 1 hour alarm level in Germany about 2 fold; the UFP exposure is in the range of 
current PM10 and PM2.5 threshold levels.
At experimental visits, participants were continuously exposed for 3 h (Supplementary Fig. S2). During the 
exposure period subjects underwent alternating 15-min cycles of rest and exercise at previously determined 
workload (Supplementary Methods). The approach has been used in numerous challenge studies worldwide and 
guarantees a sufficient inflammatory response26. We monitored ECG and oxygen saturation continuously and 
measured brachial blood pressure twice at the end of each cycle. Following exposure, subjects ingested a stand-
ardized light lunch. Then, they were instrumented for cardiovascular and autonomic measurements which started 
approximately 1.5 h after the exposure. Finally, ~3.5 h after the end of the exposure, participants were subjected 
to sputum induction (Supplementary Methods) before they went home. The inflammatory response after a 3-h 
exposure to 250 ppb O3 can already be detected 1 h after exposure and lasts at least for 24 h. The chosen time 
window for autonomic, cardiovascular, and sputum measurements corresponds to the inflammatory response27.
Measurements. Subjects were instrumented in the supine position in a quiet laboratory at an ambient 
temperature of 22–23 °C. We inserted an antecubital venous catheter and continuously recorded respiration, 
ECG, thoracic impedance (Cardioscreen, Medis GmbH, Ilmenau, Germany), and beat-by-beat finger blood 
pressure (Finometer, FMS, Arnhem, The Netherlands). We also measured brachial blood pressure with an 
automated oscillometric device (Dinamap, GE Medical Systems, Milwaukee, WI, USA) and cardiac output by 
inert gas rebreathing (Innocor, Innovision, Odense, Denmark). We recorded postganglionic, multiunit mus-
cle sympathetic nerve activity (MSNA) from within the peroneal nerve. After achieving stable resting baseline, 
respiration, blood pressure, heart rate, and MSNA were recorded for 10 minutes followed by cardiac output meas-
urements and venous sampling for catecholamine, renin, and dihydroxyphenylglycol (DHPG) determination 
(Supplementary Methods)28–30. Then, subjects underwent controlled slow breathing (6 breaths per minute) and a 
Valsalva manoeuvre for hemodynamic and autonomic assessment. Thereafter, we obtained venous blood samples 
for inflammatory marker quantification. Finally, we used procedures for sputum induction and flow cytometry of 
sputum cells as described previously31. We obtained estimates of heart rate and systolic blood pressure variability 
from 5-min supine rest recordings. Spontaneous cardiac baroreflex sensitivity was calculated as the slope of the 
linear regression between instantaneous systolic blood pressure and subsequent R-R intervals using the sequence 
method32 or by cross-spectral transfer function analysis in the low-frequency range between 0.05 and 0.15 Hz 
(Supplementary Methods).
Statistics. We planned the study to test the following hypotheses: In healthy older subjects, experimental 
exposure to carbon black UFP increases sympathetic nervous system activity compared with filtered Air sham 
exposure (primary hypothesis). Moreover, combined UFP + O3 exposure increases sympathetic nervous sys-
tem activity more than UFP exposure alone (secondary hypothesis). The primary endpoint of the study was 
5-min resting MSNA burst frequency [bursts/min]. Secondary endpoints were resting MSNA burst incidence 
[bursts/100 heart beats], which corrects MSNA for heart rate, and total MSNA [arbitrary units], which takes 
into account burst strength. We also explored arterial blood pressure, heart rate, cardiac output, blood pressure 
and heart rate variability, baroreflex sensitivity, plasma norepinephrine, DHPG, and renin concentrations, and 
inflammation parameters.
Analysis of the primary endpoint was performed using an analysis of variance (ANOVA) model that allows 
for the adjustment for period effects according to the Hills-Armitage approach using a fixed effects model 
(Supplementary Methods)33. A closed testing procedure was used to preserve a two-sided type-I error of 0.05: 
The overall test in the ANOVA had to have a P value < 0.05 to proceed to pairwise comparisons between exposure 
groups. All remaining parameters were analysed by repeated measures ANOVA without adjustment for multi-
ple comparisons. Exposure information is expressed as median ± interquartile range (IQR); physiologic data are 
expressed as mean ± SD. For primary endpoint contrasts confidence intervals [CI] are also provided.
Results
Experimental exposure to UFP and O3. During exposure with Air, UFP, and UFP + O3 particle mass 
concentrations were 19.9 ± 10.2, 68.5 ± 13.7, and 69.1 ± 19.8 µg/m³, respectively. UFP diameters were 50.6 ± 1.9 
(UFP alone) and 47.5 ± 3.6 nm (UFP + O3) with a mean geometric standard deviation in particle size of 1.7 nm. 
The median O3 concentration during UFP + O3 exposure was 249.5 ± 3.7 ppb. Median relative humidity was 
42.1 ± 11.6, 36.3 ± 10.4, and 41.5 ± 11.1% with median temperatures of 22.6 ± 0.3, 22.7 ± 0.2, and 22.6 ± 0.2 °C 
during exposure to Air, UFP, and UFP + O3, respectively.
Combined exposure to UFP + O3 elicits local pulmonary inflammation affecting pulmonary 
function. UFP exposure alone did not significantly change inflammatory markers. In contrast, the percentage 
of neutrophils in induced sputum (P < 0.001), serum club cell protein (CC16) levels (P < 0.001), and blood leu-
kocytes (P < 0.001) were significantly increased following combined UFP + O3 exposure (Fig. 1, Supplementary 
Table S1). Serum myeloperoxidase, malondialdehyde, and high-sensitivity C-reactive protein did not change. 
Localized pulmonary inflammation with UFP + O3 was associated with modest impairments in lung function 
(Supplementary Table S1). Over 3 h of intermittent exercise in Air we observed increases in forced vital capacity 
(ΔFVC: 191 ± 180 ml, P < 0.001) and forced expiratory volume in one second (ΔFEV1: 102 ± 89 ml, P < 0.001). 
Such increases were lacking with combined UFP + O3 exposure (ΔFVC: 8 ± 343 ml, P = 0.918; ΔFEV1: 
−57 ± 210 ml, P = 0.262). During the microneurographic measurements approximately 2 h after combined 
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UFP + O3 exposure, respiratory rate tended to be slightly elevated (P = 0.085, Table 2). These findings are in line 
with the idea that acute O3–induced lung function changes are dominated by involuntary inhibition of inspira-
tion34. Lung function was unchanged with UFP exposure alone suggesting that both pollutants may interact in 
terms of pulmonary inflammation and that inflammation is required to acutely perturb pulmonary function. 
Nevertheless, exposures were well tolerated and we did not observe clinically relevant changes in lung function, 
reduced oxygen saturation, or serious adverse events.
Evidence for increased systemic norepinephrine availability. We conducted a detailed biochemi-
cal catechol analysis to gauge influences of experimental air pollution on peripheral catecholamine availability 
and metabolism. UFP alone did not elicit changes in venous plasma epinephrine or norepinephrine concentra-
tions. However, following UFP + O3, we observed a significant increase in plasma norepinephrine concentrations 
(P = 0.020, Table 3) while plasma epinephrine did not change (P = 0.254). The half-life of catecholamines in 
plasma is less than 2 mins. Therefore, increased norepinephrine levels more than 1.5 h after the exposure can-
not be explained by sympathetic activation during exposure. Much of the released norepinephrine is taken up 
through the neuronal norepinephrine transporter (uptake 1) and subsequently metabolized via monoamine oxi-
dases to dihydroxyphenylglycol (DHPG). Therefore, plasma DHPG and the DHPG to norepinephrine ratio can 
be utilized to assess norepinephrine clearance mechanisms. Following UFP + O3, we observed a reduction in 
the DHPG to norepinephrine ratio (P = 0.016, Table 3, Fig. 2). The finding suggests that the increase in venous 
plasma norepinephrine following UFP + O3 is caused at least in part by reduced peripheral norepinephrine 
uptake and metabolism.
Changes in norepinephrine availability are not explained by altered central autonomic nervous 
system regulation. Muscle sympathetic nerve activity (MSNA) measurements through microneurography 
Figure 1. Inflammatory markers (n = 18). The plots show individual differences of inflammatory markers 
with ultrafine particles or ultrafine particles + ozone compared with filtered air. Only combined ultrafine 
particles + ozone exposure caused an increase in these markers. Serum malondialdehyde and high-sensitivity 
C-reactive protein did not change with exposure and have been omitted. Upper panel: Neutrophils in sputum 
that has been obtained ~3.5 h after the end of exposure. Lower panels: Club cell protein levels (CC16) and 
leukocytes in blood samples that have been obtained ~2.5 h after the end of exposure.
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are considered the Gold standard to assess vasoconstrictor sympathetic nerve traffic in human beings. Figure 3 
illustrates representative MSNA recordings during the three-sequence crossover study for three subjects with dif-
ferent exposure sequences. MSNA and neurohumoral data are presented in Table 3, Fig. 2, and in Supplementary 
Table S2. We did not observe clinically relevant differences in MSNA burst frequency between exposures. The 
overall test yielded a P value of 0.633, and all pairwise comparisons expressed in bursts/min were UFP + O3 
minus UFP: −2.3, 95% CI [−8.5, 3.9], P = 0.458; Air minus UFP: 0.5, 95% CI [−5.8, 6.7], P = 0.883; UFP + O3 
minus Air: −2.8, 95% CI [−9.0, 3.5], P = 0.376. Moreover, also MSNA burst incidence and MSNA total activ-
ity did not differ between exposures. Overall, these observations exclude a major change in centrally generated 
sympathetic activity with experimental air pollution. The conclusion is supported by the observation that plasma 
renin concentrations, which respond to changes in renal sympathetic drive, did not increase with experimental 
Parameter Air UFP UFP + O3 P value
During exposure (rest between exercise bouts)
  SBP [mm Hg] 118 ± 12 119 ± 11 120 ± 11 0.481
  DBP [mm Hg] 72 ± 8 73 ± 7 73 ± 7 0.417
  HR [bpm] 75 ± 11 74 ± 12 73 ± 12 0.644
After exposure (supine rest during microneurography)
  SBP [mm Hg] 125 ± 16 126 ± 17 126 ± 16 0.760
  DBP [mm Hg] 74 ± 10 73 ± 9 73 ± 9 0.676
  HR [bpm] 73 ± 9 74 ± 11 73 ± 12 0.802
  CO [l/min] 6.70 ± 1.01 6.93 ± 0.88 6.82 ± 1.14 0.771
  TPR [dyn × s/cm−5] 1000 ± 183 986 ± 221 991 ± 218 0.954
  fResp [breaths/min] 15.0 ± 2.6 15.4 ± 2.9 16.2 ± 3.1 0.085
Table 2. Resting hemodynamics and respiration during and after exposure (mean ± SD). HR: Heart rate, SBP: 
Systolic blood pressure, DBP: Diastolic blood pressure, CO: Cardiac output, TPR: Total peripheral resistance, 
fResp: Respiratory rate.
Parameter Air UFP UFP + O3 P value
MSNA (burst frequency, burst incidence, total activity)
  [bursts/min] 47.2 ± 12.3 46.9 ± 14.5 44.8 ± 14.0 0.633
  [bursts/100 heart beats] 64.6 ± 13.5 63.2 ± 15.3 61.7 ± 17.1 0.672
  [au] 2.97 ± 2.16 2.75 ± 1.46 2.75 ± 1.47 0.827
Catechol derivatives
  Dopamine [ng/l] 17.3 ± 12.9 15.5 ± 8.5 18.7 ± 8.3 0.256
  Epinephrine [ng/l] 18.3 ± 11.7 17.4 ± 12.0 21.0 ± 14.3 0.254
  NE [ng/l] 356 ± 125 340 ± 146 404 ± 124 0.020*
  NE/MSNA [ng/l/au] 164 ± 89 150 ± 84 190 ± 106 0.278
  DHPG [ng/l] 1865 ± 443 1912 ± 576 1799 ± 373 0.551
  DHPG/NE 5.56 ± 1.64 6.21 ± 2.60 4.66 ± 1.17 0.016*
RR interval variability
  LF [ms²] 425 ± 545 524 ± 675 547 ± 991 0.626
  HF [ms²] 166 ± 287 183 ± 305 241 ± 536 0.355
  TP [ms²] 1132 ± 1194 1416 ± 1512 1147 ± 1585 0.171
  LF/HF ratio 3.45 ± 2.88 3.89 ± 2.79 3.39 ± 2.72 0.760
  SD [ms] 33.1 ± 15.2 38.2 ± 19.6 34.3 ± 21.2 0.258
  RMSSD [ms] 21.6 ± 16.2 22.4 ± 16.6 25.8 ± 26.0 0.385
SBP variability
  LF [mm Hg²] 16.2 ± 16.6 14.8 ± 10.4 14.3 ± 8.6 0.858
Baroreflex sensitivity (baroreflex gain) [ms/mm Hg]
  Down sequences 7.0 ± 3.3 6.1 ± 2.8 6.2 ± 3.5 0.283
  Up sequences 6.8 ± 3.7 6.1 ± 2.8 6.9 ± 4.9 0.514
  Cross-spectral analysis 5.4 ± 2.4 5.5 ± 2.8 6.2 ± 4.1 0.501
Table 3. Autonomic nervous system after exposure (mean ± SD). MSNA: Muscle sympathetic nerve activity, 
au: Total MSNA in arbitrary units per minute, NE: Plasma norepinephrine, DHPG: Dihydroxyphenylglycol, 
*Significant difference between UFP and UFP + O3 (see also Fig. 2 for differences vs Air). VLF: Very low 
frequency band, LF: Low frequency band, HF: High frequency band, TP: Total power, SD: Standard deviation of 
RR intervals, RMSSD: Root mean square of successive RR interval differences, SBP: Systolic blood pressure.
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air pollution (22.5 ± 42.1, 16.5 ± 21.8, and 15.3 ± 12.0 ng/l following exposure to Air, UFP, and UFP + O3, respec-
tively P = 0.425).
Next, we computed indirect measures for autonomic cardiovascular control that respond to changes in central 
nervous sympathetic or parasympathetic control (Table 3). Systolic blood pressure variabilities were comparable 
following exposure to Air, UFP, or UFP + O3. RR interval variability and cardiac baroreflex gain, which are related 
to cardiac vagal activity, did not differ between interventions. Likewise, maximum sympathetic response during 
Valsalva phase IIb was similar as was respiratory sinus arrhythmia with deep breathing and Valsalva ratio as indi-
ces of parasympathetic heart rate control. Thus, modest experimental air pollution while producing pulmonary 
inflammation and changes in lung function is not sufficient to perturb central sympathetic or parasympathetic 
cardiovascular control mechanisms. Since sympathetic nerve traffic and the relation between norepinephrine 
and MSNA were unchanged, the increase in norepinephrine with UFP + O3 cannot be explained by augmented 
centrally generated sympathetic outflow.
Altered norepinephrine availability does not translate into changes in hemodynamic meas-
urements. Resting hemodynamic and respiration data obtained during microneurography measurements 
are provided in Table 2. Hemodynamics were similar between study days. We reasoned that influences of experi-
mental air pollution on hemodynamics could be unmasked during states of raised sympathetic activity. Therefore, 
we also assessed hemodynamic responses during exercise in the exposure chamber (see Supplementary Fig. S3 
for individual data). Heart rate and systolic blood pressure increased similarly with exercise on the three study 
days (Air: 41.9 ± 11.4, UFP: 37.2 ± 14.3, UFP + O3: 38.1 ± 15.8 bpm, P = 0.350; Air: 29.5 ± 12.9, UFP: 26.7 ± 11.6, 
UFP + O3: 27.0 ± 13.9 mm Hg, P = 0.488). Diastolic blood pressure increased less with UFP vs. UFP + O3 (Air: 
2.7 ± 7.5, UFP: 0.4 ± 4.7, UFP + O3: 4.5 ± 6.9 mm Hg, P = 0.028). Resting hemodynamics between the 15-min 
exercise bouts were similar during all exposures (Table 2). Thus, in otherwise healthy older persons, experimental 
Figure 2. Catechols (n = 18). The plots show individual differences of catechols with ultrafine particles (UFP) 
or UFP + ozone (O3) compared with filtered air. Assuming the null hypothesis, the mean of the data points 
would fall on the zero line (dashed line). Combined exposure to UFP + O3 tended to increase norepinephrine 
plasma levels (NE, upper panel). The ratio between dihydroxyphenylglycol (DHPG, middle panel) and NE 
may serve as biochemical indicator for norepinephrine reuptake (lower panel). Its decrease could explain the 
increase in plasma NE.
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air pollution while eliciting pulmonary inflammation and reduced norepinephrine turnover does not produce 
major changes in blood pressure and heart rate control at rest or during physical exercise.
Discussion
Our study is the first examining the effects of rigorously controlled short-term experimental exposure to UFP 
with and without O3 on directly measured sympathetic activity. The main finding is that the exposure did not 
elicit clinically relevant changes in sympathetic activity at rest or during sympathetic stimulation. However, we 
observed an about 13% increase in venous norepinephrine concentrations with reduction in the DHPG to norep-
inephrine ratio following combined UFP + O3 exposure. By comparison, smoking 20 cigarettes per day over one 
week increased plasma norepinephrine approximately 10% compared with air inhalation35. Our study suggests 
diminished catecholamine clearance, a hitherto unknown mechanism through which environmental pollutants 
may perturb human adrenergic responses. In healthy subjects small amounts of pressor compounds do not trans-
late into blood pressure increases as they are effectively balanced by counterregulatory responses, such as baro-
reflexes. In diseased subjects with elevated sympathetic activity and diminished baroreflex function, however, 
reduced norepinephrine reuptake may have detrimental effects.
Highly controlled exposure to environmental pollutants in a rigorously designed double-blind and crossover 
fashion is a particular strength of our study. Measured exposures to UFP and O3 were rather stable with little 
deviation from planned experimental conditions. We applied UFP and O3 concentrations that are known to 
elicit biological responses in human subjects. Carbon UFP inhalation in concentrations applied in our study 
transiently activated platelets in patients with type-2 diabetes mellitus36. Unlike UFP exposure, which is known 
to have a limited effect on human airway inflammation, addition of O3 elicited a robust inflammatory response. 
In fact, sputum neutrophil counts and circulating inflammatory markers increased sharply. In induced sputum, 
the magnitude of the inflammatory response to combined UFP + O3 exposure was similar to studies applying O3 
only37. Bronchial biopsies taken following acute O3 exposure in healthy subjects showed increased percentage of 
neutrophils and total protein concentration38,39.
Combining microneurography with hemodynamic measurements, plasma catecholamine determination, and 
heart rate as well as blood pressure variability analysis provided comprehensive insight in cardiovascular auto-
nomic responses to experimental air pollution. It has been speculated that environmental pollutants may engage 
afferent neural pathways in the lung or elsewhere in the body, thereby changing autonomic balance towards 
sympathetic predominance. In fact, O3 responsive bronchial C fibres have been demonstrated in anesthetized 
and artificially ventilated dogs40. Due to their size, UFP may pass the alveolo-capillary barrier41 and enter the 
brain42 where they could directly affect autonomic circuits. Yet, we did not observe clinically relevant changes 
Figure 3. Original muscle sympathetic nerve activity (MSNA) recordings. Representative MSNA recordings 
(30-s segments) in 3 subjects with differing exposure sequences. There is no indication of sympathetic activation 
during exposure to ultrafine particles with or without additional ozone.
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in MSNA at rest, during deep breathing, or during baroreflex-mediated sympathetic activation elicited by the 
Valsalva manoeuvre. Blood pressure and heart rate did not respond either. Furthermore, blood pressure and heart 
rate recordings during exposure did not differ between interventions. Our findings challenge the idea that UFP 
with or without O3 elicit substantial changes in centrally generated sympathetic activity or parasympathetic heart 
rate control.
The plasma norepinephrine increase following UFP + O3 exposure cannot be explained by increased central 
sympathetic drive because MSNA did not change. Dissociation between circulating norepinephrine and MSNA 
could result from altered coupling between electrical nerve activity and transmitter release or changed norepi-
nephrine uptake/metabolism. Approximately 80–90% of the released norepinephrine is taken up again by the 
norepinephrine transporter and either repackaged or enzymatically degraded by monoamine oxidases to DHPG. 
Therefore, the DHPG to norepinephrine ratio has been proven useful as biochemical marker for neural norepi-
nephrine uptake and metabolism43. Indeed, genetic norepinephrine transporter deficiency44 and pharmacological 
norepinephrine transporter inhibition45–47 feature reductions in the ratio between plasma DHPG and norepi-
nephrine. The observation that the ratio was reduced following exposure to UFP + O3 is consistent with reduction 
in norepinephrine uptake and metabolism through this pathway. Besides their expression on adrenergic neurons, 
norepinephrine transporters are also present on lung endothelial cells48,49, and contribute to catecholamine clear-
ance in newborn lambs, in dogs, and in human subjects50–52. We cannot differentiate individual contributions of 
lung endothelium and adrenergic neurons to the change in the DHPG/norepinephrine ratio. Particulate matter 
inhalation causes endothelial injury, reflected by circulating endothelial microparticles derived from apoptosis53. 
We speculate that pulmonary endothelial inflammation could affect endothelial catecholamine clearance through 
the norepinephrine transporter. If so, reduced clearance could augment catecholamine concentrations entering 
the coronary circulation, particularly during profound sympathoadrenal activation. We cannot exclude that other 
local or systemic changes, that are affected by UFP + O3 exposure, contributed to the response. The cellular regu-
lation of the norepinephrine transporter has been studied in great detail54. For example, protein kinase-C, which 
is targeted by multiple neurotransmitters and hormones, affects norepinephrine transporter trafficking. Yet, 
whether and how these mechanisms contribute to norepinephrine uptake in human beings is largely unknown.
Limitations
Our study was sufficiently powered to detect clinically relevant changes in MSNA. We cannot exclude subtle 
changes in cardiovascular autonomic control that may be relevant on the population level. Yet, MSNA was numer-
ically lower following UFP exposures compared to filtered air. Furthermore, environmental fine particles contain 
minerals, metals, road dust, combustion residues, SO2 and NOX from fires and engine exhaust among others. 
Particle composition depends on sources, site, season, and weather conditions55. Potential interactions between 
components of airborne substance mixtures on human health have been poorly investigated56. Observations on 
carbon UFP cannot be simply extrapolated to environmental UFP exposure. In any event, exposure to particles 
sampled at different locations produced differential cardiovascular responses in human subjects57. We did not 
obtain a full dose-response relationship between exposure and cardiovascular autonomic regulation. We used a 
short-term exposure model whereas typical ambient air pollution periods are of longer duration and often repeti-
tive. Yet, even two-hour exposure may trigger cardiovascular events3,8. Our idea was to assess autonomic function 
using microneurography and plasma sampling when the inflammatory process is fully developed. However, we 
cannot rule out that there is inflammation-independent sympathetic excitation that would have been detected 
only during or shortly after the exposure. Finally, we studied older otherwise healthy individuals and, therefore, 
cannot exclude more marked responses in patients with established cardiovascular or pulmonary disease.
Conclusions
The epidemiological evidence implicating environmental pollutants in cardiovascular morbidity and mortality is 
compelling. Since a larger proportion of the world population will live in urban environments in the future, the 
relevance of these mechanisms for cardiovascular health may increase further. Yet, epidemiological studies have 
their limitations in discerning the contribution of individual pollutants on cardiovascular health and may not 
suffice to design targeted interventions. The fact that air pollution and environmental noise58, which commonly 
occur together, are both associated with increased cardiovascular risk is a prime example. Our observations sug-
gest that exposure to well-defined pollutants in a rigorously controlled environment combined with high-fidelity 
human phenotyping is suitable to confirm or to exclude hypotheses generated in large-scale epidemiological 
studies and to gain mechanistic insight. While acute UFP exposure with or without O3 did not alter central sym-
pathetic or parasympathetic activity, we observed subtle changes in peripheral catechols with combined exposure 
to UFP and O3 consistent with impaired norepinephrine uptake and metabolism. We suggest that the pulmonary 
inflammatory response may have perturbed pulmonary endothelial norepinephrine clearance.
Data Availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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